Nascent Biotech, Inc. (NBIO)
OTCMKTS: NBIO · Delayed Price · USD
0.0999
+0.0146 (17.16%)
Apr 24, 2024, 11:03 AM EDT - Market open

Nascent Biotech Market Cap

Nascent Biotech has a market cap or net worth of $16.96 million as of April 24, 2024. Its market cap has increased by 63.72% in one year.

Market Cap
16.96M
Enterprise Value
16.46M
1-Year Change
63.72%
Ranking
n/a
Category
Stock Price
$0.10

Market Cap Chart

Since April 25, 2019, Nascent Biotech's market cap has increased from $5.85M to $16.96M, an increase of 189.93%. That is a compound annual growth rate of 23.73%.

History

DateMarket Cap% Change
Apr 23, 202414.26M-5.10%
Apr 22, 202415.03M-4.02%
Apr 19, 202415.66M1.36%
Apr 18, 202415.45M-3.30%
Apr 16, 202415.97M-20.22%
Apr 15, 202420.02M8.97%
Apr 12, 202418.37M23.43%
Apr 11, 202414.88M0.23%
Apr 10, 202414.85M-
Apr 9, 202414.85M4.78%
Apr 8, 202414.17M-29.38%
Apr 5, 202420.07M-29.41%
Apr 4, 202428.43M-
Apr 3, 202428.43M-5.56%
Apr 2, 202430.10M-2.44%
Mar 26, 202430.86M13.02%
Mar 25, 202427.30M-9.81%
Mar 22, 202430.27M1.12%
Mar 21, 202429.94M22.60%
Mar 20, 202424.42M5.04%
Mar 19, 202423.25M1.46%
Mar 18, 202422.91M-
Mar 15, 202422.91M1.48%
Mar 14, 202422.58M-0.37%
Mar 13, 202422.66M-0.13%
View and export this data all the way back to 2019. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly 708.98B
Novo Nordisk 559.94B
UnitedHealth Group 448.23B
Johnson & Johnson 360.41B
Merck & Co. 321.34B
AbbVie 300.20B
AstraZeneca 219.62B
Thermo Fisher 219.33B
Market Cap Rankings